FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ZALIFRELIMAB
异名/同义词A HUMAN MONOCLONAL ANTIBODY TARGETING CYTOTOXIC T LYMPHOCYTE ASSOCIATED PROTEIN 4 (CTLA4)
AGEN1884
AGEN-1884
ANTI-CTLA-4 MONOCLONAL ANTIBODY AGEN1884
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN MONOCLONAL AGEN1884 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AGEN1884 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC TLYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152))
UGN-301
ZALIFRELIMAB
ZALIFRELIMAB [INN]
ZALIFRELIMAB [USAN]
ZALIFRELIMAB [WHO-DD]
CAS登记号2148321-69-9
物质唯一标识(Unique Ingredient Identifier)FE7L22H028
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System